Dr. Mark Howarth

Biography

Professor Mark Howarth is a research leader in the Department of Pharmacology at the University of Cambridge, specializing in innovative protein technologies for therapeutic and vaccine design. His academic journey began with graduate work in molecular immunology at the University of Oxford and the University of Southampton, followed by postdoctoral research at MIT, where he focused on chemical biology and advanced microscopy techniques. He previously served as a Professor of Protein Nanotechnology at the University of Oxford, receiving notable recognition including the Royal Society of Chemistry's Norman Heatley Prize in Chemical Biology. As the founder of SpyBiotech, he has led clinical trials in vaccine development and has established multiple successful start-up ventures. His research integrates insights from synthetic biology, protein engineering, and immunology to explore advanced therapeutics, particularly in the context of cancer and infectious diseases. He is actively involved in teaching, providing workshops in entrepreneurship and translational research to undergraduate and graduate students. Professor Howarth's work is widely supported by grants from various research councils and collaborations with multiple pharmaceutical and biotechnology companies.

Research Interests